View in EDS HTML Full Text PDF Full Text

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium.

Saved in:
Bibliographic Details
Title: Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium.
Authors: Afrough A; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. Aimaz.afrough@utsouthwestern.edu., Hashmi H; Medical University of South Carolina, Charleston, SC, USA., Hansen DK; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Sidana S; Stanford University School of Medicine, Stanford, CA, USA., Ahn C; Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX, USA., Peres LC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Dima D; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Freeman CL; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Puglianini OC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Kocoglu MH; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Atrash S; Levine Cancer Institute, Charlotte, NC, USA., Voorhees PM; Levine Cancer Institute, Charlotte, NC, USA., Shune L; The University of Kansas Medical Center, Kansas City, KS, USA., McGuirk JP; The University of Kansas Medical Center, Kansas City, KS, USA., Simmons G; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA., Sborov DW; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Davis JA; Medical University of South Carolina, Charleston, SC, USA., Kaur G; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Sannareddy A; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Ferreri CJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gaballa MR; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Goldsmith S; City of Hope National Medical Center, Duarte, CA, USA., Nadeem O; Dana-Farber Cancer Institute, Boston, MA, USA., Midha S; Dana-Farber Cancer Institute, Boston, MA, USA., Wagner CB; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Locke FL; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Patel KK; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Anderson LD Jr; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. larry.anderson@utsouthwestern.edu., Lin Y; Mayo Clinic, Rochester, MN, USA.
Source: Blood cancer journal [Blood Cancer J] 2024 Apr 12; Vol. 14 (1), pp. 63. Date of Electronic Publication: 2024 Apr 12.
Publication Type: Letter
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38609386
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Afrough+A%22">Afrough A</searchLink>; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. Aimaz.afrough@utsouthwestern.edu.<br /><searchLink fieldCode="AU" term="%22Hashmi+H%22">Hashmi H</searchLink>; Medical University of South Carolina, Charleston, SC, USA.<br /><searchLink fieldCode="AU" term="%22Hansen+DK%22">Hansen DK</searchLink>; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Sidana+S%22">Sidana S</searchLink>; Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ahn+C%22">Ahn C</searchLink>; Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Peres+LC%22">Peres LC</searchLink>; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Dima+D%22">Dima D</searchLink>; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Freeman+CL%22">Freeman CL</searchLink>; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Puglianini+OC%22">Puglianini OC</searchLink>; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Kocoglu+MH%22">Kocoglu MH</searchLink>; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Atrash+S%22">Atrash S</searchLink>; Levine Cancer Institute, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Voorhees+PM%22">Voorhees PM</searchLink>; Levine Cancer Institute, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Shune+L%22">Shune L</searchLink>; The University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22McGuirk+JP%22">McGuirk JP</searchLink>; The University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Simmons+G%22">Simmons G</searchLink>; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA.<br /><searchLink fieldCode="AU" term="%22Sborov+DW%22">Sborov DW</searchLink>; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Davis+JA%22">Davis JA</searchLink>; Medical University of South Carolina, Charleston, SC, USA.<br /><searchLink fieldCode="AU" term="%22Kaur+G%22">Kaur G</searchLink>; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Sannareddy+A%22">Sannareddy A</searchLink>; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ferreri+CJ%22">Ferreri CJ</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Gaballa+MR%22">Gaballa MR</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Goldsmith+S%22">Goldsmith S</searchLink>; City of Hope National Medical Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nadeem+O%22">Nadeem O</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Midha+S%22">Midha S</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wagner+CB%22">Wagner CB</searchLink>; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Locke+FL%22">Locke FL</searchLink>; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Patel+KK%22">Patel KK</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Khouri+J%22">Khouri J</searchLink>; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+LD+Jr%22">Anderson LD Jr</searchLink>; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. larry.anderson@utsouthwestern.edu.<br /><searchLink fieldCode="AU" term="%22Lin+Y%22">Lin Y</searchLink>; Mayo Clinic, Rochester, MN, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2024 Apr 12; Vol. 14 (1), pp. 63. <i>Date of Electronic Publication: </i>2024 Apr 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38609386
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-024-00993-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 63
    Titles:
      – TitleFull: Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Afrough A
      – PersonEntity:
          Name:
            NameFull: Hashmi H
      – PersonEntity:
          Name:
            NameFull: Hansen DK
      – PersonEntity:
          Name:
            NameFull: Sidana S
      – PersonEntity:
          Name:
            NameFull: Ahn C
      – PersonEntity:
          Name:
            NameFull: Peres LC
      – PersonEntity:
          Name:
            NameFull: Dima D
      – PersonEntity:
          Name:
            NameFull: Freeman CL
      – PersonEntity:
          Name:
            NameFull: Puglianini OC
      – PersonEntity:
          Name:
            NameFull: Kocoglu MH
      – PersonEntity:
          Name:
            NameFull: Atrash S
      – PersonEntity:
          Name:
            NameFull: Voorhees PM
      – PersonEntity:
          Name:
            NameFull: Shune L
      – PersonEntity:
          Name:
            NameFull: McGuirk JP
      – PersonEntity:
          Name:
            NameFull: Simmons G
      – PersonEntity:
          Name:
            NameFull: Sborov DW
      – PersonEntity:
          Name:
            NameFull: Davis JA
      – PersonEntity:
          Name:
            NameFull: Kaur G
      – PersonEntity:
          Name:
            NameFull: Sannareddy A
      – PersonEntity:
          Name:
            NameFull: Ferreri CJ
      – PersonEntity:
          Name:
            NameFull: Gaballa MR
      – PersonEntity:
          Name:
            NameFull: Goldsmith S
      – PersonEntity:
          Name:
            NameFull: Nadeem O
      – PersonEntity:
          Name:
            NameFull: Midha S
      – PersonEntity:
          Name:
            NameFull: Wagner CB
      – PersonEntity:
          Name:
            NameFull: Locke FL
      – PersonEntity:
          Name:
            NameFull: Patel KK
      – PersonEntity:
          Name:
            NameFull: Khouri J
      – PersonEntity:
          Name:
            NameFull: Anderson LD Jr
      – PersonEntity:
          Name:
            NameFull: Lin Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 04
              Text: 2024 Apr 12
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1